Viking Fund Management Has Raised Its Oneok New (OKE) Position; Alyeska Investment Group LP Lifted Its Biomarin Pharmaceutical (BMRN) Holding

July 3, 2017 - By Michael Collier

Viking Fund Management Llc increased Oneok Inc. New (OKE) stake by 61.15% reported in 2016Q4 SEC filing. Viking Fund Management Llc acquired 79,500 shares as Oneok Inc. New (OKE)’s stock declined 4.12%. The Viking Fund Management Llc holds 209,500 shares with $12.03M value, up from 130,000 last quarter. Oneok Inc. New now has $11.14 billion valuation. It closed at $52.16 lastly. It is down 23.81% since July 3, 2016 and is uptrending. It has outperformed by 7.11% the S&P500.

Alyeska Investment Group Lp increased Biomarin Pharmaceutical Inc (BMRN) stake by 7.97% reported in 2016Q4 SEC filing. Alyeska Investment Group Lp acquired 64,453 shares as Biomarin Pharmaceutical Inc (BMRN)’s stock declined 0.71%. The Alyeska Investment Group Lp holds 872,701 shares with $72.30M value, up from 808,248 last quarter. Biomarin Pharmaceutical Inc now has $15.99B valuation. It closed at $90.82 lastly. It is down 5.29% since July 3, 2016 and is uptrending. It has underperformed by 11.41% the S&P500.

Among 14 analysts covering ONEOK (NYSE:OKE), 3 have Buy rating, 0 Sell and 11 Hold. Therefore 21% are positive. ONEOK had 37 analyst reports since August 11, 2015 according to SRatingsIntel. The stock of ONEOK, Inc. (NYSE:OKE) has “Overweight” rating given on Wednesday, January 20 by Morgan Stanley. As per Wednesday, June 14, the company rating was upgraded by UBS. Credit Suisse upgraded the shares of OKE in report on Thursday, February 2 to “Outperform” rating. The stock of ONEOK, Inc. (NYSE:OKE) has “Neutral” rating given on Monday, February 8 by Robert W. Baird. The firm earned “Buy” rating on Friday, June 17 by Citigroup. Jefferies downgraded ONEOK, Inc. (NYSE:OKE) on Thursday, January 12 to “Underperform” rating. The stock of ONEOK, Inc. (NYSE:OKE) earned “Hold” rating by Jefferies on Thursday, February 23. The stock of ONEOK, Inc. (NYSE:OKE) earned “Buy” rating by Argus Research on Monday, January 11. The rating was downgraded by Oppenheimer to “Perform” on Friday, January 22. The firm has “Hold” rating by RBC Capital Markets given on Monday, May 15.

Investors sentiment increased to 1.21 in 2016 Q4. Its up 0.01, from 1.2 in 2016Q3. It is positive, as 37 investors sold OKE shares while 165 reduced holdings. 68 funds opened positions while 176 raised stakes. 153.12 million shares or 3.46% more from 148.00 million shares in 2016Q3 were reported. Apg Asset Mgmt Nv, a Netherlands-based fund reported 422,083 shares. New Mexico Educational Retirement Board accumulated 22,460 shares or 0.06% of the stock. Everett Harris Communications Ca reported 0.05% of its portfolio in ONEOK, Inc. (NYSE:OKE). New Jersey Better Educational Savings Trust owns 9,000 shares. Thompson Davis Company reported 0.04% of its portfolio in ONEOK, Inc. (NYSE:OKE). Conning Inc holds 0.01% or 5,236 shares in its portfolio. Lpl Fin Ltd Company reported 50,845 shares. Ontario Teachers Pension Plan Board reported 0.01% stake. Bessemer Grp Inc has 53,150 shares for 0.01% of their portfolio. Asset Management Inc has 0.04% invested in ONEOK, Inc. (NYSE:OKE) for 20,153 shares. Mark Sheptoff Planning Ltd Liability Com holds 400 shares or 0.02% of its portfolio. Keybank Association Oh accumulated 10,800 shares. Commerzbank Aktiengesellschaft Fi owns 7,414 shares. Ubs Asset Mgmt Americas holds 0.04% or 569,937 shares. Jefferies Group Ltd Com has invested 0% in ONEOK, Inc. (NYSE:OKE).

Viking Fund Management Llc decreased Oge Energy Corp (NYSE:OGE) stake by 20,000 shares to 260,000 valued at $8.70M in 2016Q4. It also reduced Tesoro Corp (NYSE:TSO) stake by 80,000 shares and now owns 175,000 shares. Westlake Chemical Corp (NYSE:WLK) was reduced too.

Among 20 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 13 have Buy rating, 0 Sell and 7 Hold. Therefore 65% are positive. BioMarin Pharmaceutical had 43 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has “Outperform” rating given on Thursday, April 7 by BMO Capital Markets. The rating was maintained by Wedbush on Tuesday, August 25 with “Neutral”. The rating was maintained by Jefferies with “Buy” on Wednesday, May 31. Jefferies maintained it with “Buy” rating and $166 target in Tuesday, August 25 report. Oppenheimer maintained the stock with “Perform” rating in Wednesday, November 25 report. As per Friday, August 5, the company rating was maintained by Piper Jaffray. The firm has “Conviction Buy” rating by Goldman Sachs given on Monday, March 7. The rating was maintained by RBC Capital Markets on Friday, February 26 with “Outperform”. The company was initiated on Thursday, December 8 by Gabelli. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has “Outperform” rating given on Tuesday, March 22 by Credit Suisse.

Investors sentiment decreased to 1.04 in 2016 Q4. Its down 0.62, from 1.66 in 2016Q3. It turned negative, as 50 investors sold BMRN shares while 129 reduced holdings. 50 funds opened positions while 136 raised stakes. 165.79 million shares or 0.67% more from 164.68 million shares in 2016Q3 were reported. Tiaa Cref Inv Management Limited Liability Corporation accumulated 1.22M shares. Fmr Ltd Liability Corporation reported 0.1% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Regent Invest Mngmt Limited Com has invested 0.14% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Bb&T owns 11,536 shares or 0.02% of their US portfolio. Price T Rowe Assoc Incorporated Md has invested 0.02% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Amer International Grp Inc accumulated 16,749 shares. Partner Fund Mngmt LP holds 2.47% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) for 1.06M shares. Franklin Res accumulated 1.62M shares or 0.07% of the stock. Citadel Advsr Ltd Liability Co reported 700,737 shares or 0.06% of all its holdings. Calvert Mngmt holds 10,996 shares. Service Automobile Association accumulated 0.01% or 32,358 shares. Pictet Asset Mngmt stated it has 0.31% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Retirement Of Alabama accumulated 0.01% or 22,846 shares. Glg Ltd Liability Co accumulated 9,048 shares. Everpoint Asset Llc has invested 0.62% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN).

Since January 6, 2017, it had 0 buys, and 29 insider sales for $18.56 million activity. The insider BIENAIME JEAN JACQUES sold $441,900. $452,800 worth of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was sold by Ajer Jeffrey Robert. 9,471 shares were sold by Davis George Eric, worth $862,230 on Monday, June 5. The insider LAWLIS V BRYAN sold $712,500. Shares for $214,916 were sold by SPIEGELMAN DANIEL K. Another trade for 7,482 shares valued at $687,334 was sold by Mueller Brian. $1.35 million worth of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was sold by FUCHS HENRY J on Friday, June 16.

Alyeska Investment Group Lp decreased Bank Of Nt Butterfield&Son L stake by 145,183 shares to 1.45 million valued at $45.74 million in 2016Q4. It also reduced E L F Beauty Inc stake by 78,135 shares and now owns 24,000 shares. Radiant Logistics Inc (NYSEMKT:RLGT) was reduced too.